Report publication dubbed 'a step towards providing Irish patients with faster access to new medicines'

Ireland's Minister for Health Stephen Donnelly’s decision to publish the Mazars Report has been welcomed by the Irish Pharmaceutical Healthcare Association (IPHA).

The group will study the Mazars Report and provide any observations arising from it to Mr Donnelly.

The IPHA, which represents major international biopharmaceutical companies in Ireland, called the report’s publication a ‘positive step towards providing Irish patients with faster access to life-changing new medicines,’ and has also welcomed the establishment of a working group to review and improve the reimbursement system for new medicines.